Director Clint D. Coghill at Amplify Energy (AMPY) purchased 304,000 shares at $3.28 each for a total of $997,190, while Chief Admin. and Legal Officer Lori Freedman at Organogenesis Holdings (ORGO) bought 252,264 shares at $2.88 each, totaling $725,290; both companies saw their stock prices increase on Monday, with AMPY up 7.7% and ORGO up 13.5%, resulting in paper gains for the insiders based on the day's trading highs.
Significant insider buying activity has been reported at Amplify Energy (AMPY) and Organogenesis Holdings (ORGO), signaling potential management confidence. At Amplify Energy, Director Clint D. Coghill acquired 304,000 shares at $3.28 each, for a total investment of $997,190, marking Coghill's first such filed purchase in the past year. Subsequently, AMPY's stock rose approximately 7.7% on Monday, with the shares reaching a high of $3.59, affording Coghill an unrealized gain of about 9.4% at that point. Concurrently, Organogenesis Holdings saw its Chief Administrative and Legal Officer, Lori Freedman, purchase 252,264 shares at $2.88 per share, totaling $725,290. Organogenesis Holdings' stock experienced a notable increase of about 13.5% on Monday, with Freedman's investment showing an approximate 29.0% paper gain based on the day's trading high of $3.71. Both companies exhibit a strongly positive sentiment score of 0.8, and these transactions, categorized under 'Insider Transactions' and 'Company Fundamentals' themes, are often interpreted by the market as positive indicators for the companies' outlooks.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment
